United States (National)
Not enough data
Fred Pennic's coverage primarily focuses on the healthcare and pharmaceutical industry. His articles heavily feature press releases and private sector announcements, indicating a preference for news directly from companies in the industry.
To effectively reach Fred, consider providing exclusive details or insights into mergers and acquisitions within the healthcare sector, advancements in AI technology in healthcare, Medicare-related developments, or innovations in healthcare technology. As his focus does not seem to be confined to a specific geographic area, pitches should aim to provide valuable information relevant to global audiences within the healthcare and pharmaceutical space.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Fred Pennic
Healthcare data pioneer xCures has announced the completion of a $46M Series B financing round led by Innovius Capital, with heavy participation from iGrow, GKCC, Spring Mountain Capital, and existing institutional investors. The milestone round pushes the company’s total institutional funding past $76M, providing the working capital needed to scale its proprietary data-structuring platform across multiple medical disciplines.
By: Fred Pennic
The KLAS Arch Collaborative has released its C linician EHR Experience 2026: State of the Industry impact report, tracking EHR satisfaction benchmarks across 92 healthcare organizations and over 121,000 clinicians. A major clinical sentiment gap persists between disciplines: while 22% of physicians report an “Elite” (Level 6) EHR experience, only 12% of nurses achieve the same tier, with nurses far more likely to remain stuck in “Basic” or “Struggling” environments.
By: Fred Pennic
Cancer AI pioneer Hurone AI h as entered into a strategic know-how agreement to license Mayo Clinic’s HOUSES (HOUsing-based index of Socioeconomic Status) technology. The collaboration natively embeds Mayo Clinic’s validated social determinants of health (SDoH) tool directly into Hurone’s governed cancer navigation ecosystem.
By: Fred Pennic
The ZS Impact Institute has published its inaugural 2026 Future of Health Report, surveying over 10,000 global healthcare consumers and licensed medical doctors across the U.S., Germany, and China. A structural shift in patient orientation is taking place: approximately 90% of individuals utilizing AI and digital interfaces trust the generated health insights nearly on par with their own physicians.
Senior care coordination pioneer Hera has announced a $27M Series A funding round led by Bain Capital Ventures, with continued backing from Accel, IA Ventures, and strategic angel investors including the CFO of Mount Sinai. The platform targets an intense family caregiving crisis, using human-centric AI to centralize scattered geriatric caregiving knowledge and streamline long-term care orchestration.
By: Fred Pennic
ECG-led diagnostics software pioneer AccurKardia and Samsung SDS spin-off Wellysis have executed a multi-year agreement in Seoul to launch a turnkey cardiac monitoring solution in the United States. The strategic alliance pairs Wellysis’ S-Patch wearable ECG monitor directly with AccurKardia’s cloud-based automated analytics to streamline Holter, extended Holter, and mobile cardiac telemetry (MCT) clinical workflows.
By: Fred Pennic
The KLAS Healthcare IT Insights division has published its flagship Global Hospital EHR Market Share 2026 report, revealing that total global EHR purchasing decisions plummeted to an almost five-year marketplace low. A strict capital tightening is reshaping international margins; the volume of impacted healthcare facilities (447 hospitals) and active clinical beds (81,261) represented the lowest deployment volume tracked by KLAS in at least a decade.
By: Fred Pennic
Medical AI leader OpenEvidence has announced the commercial launch of EvidenceGrade, a new system capability that scores and visualizes the clinical certainty of cited medical literature in real time. The feature directly targets a dangerous AI limitation: standard models tend to gloss over differences in source quality, treating small, observational studies with the same weight as randomized, blinded, placebo-controlled trials.
By: Fred Pennic
Rock Health Capital H1 2026 Digital Health Funding Report, U.S. digital health funding reached $7.4B across 244 deals in H1 2026, outposing H1 2025 by $1B and establishing a clear multi-year recovery from the post-pandemic market resets of 2023 and 2024. Mega deals ($100M+) absorbed a staggering 45% of all deployed capital in H1 2026, consolidating nearly half of the market’s total funding into just 8% of finalized transactions.
By: Fred Pennic
Structural biology and AI drug design pioneer Chai Discovery has announced a $400M Series C funding round, valuing the company at $3.8 billion just two years after its 2024 founding. The heavily oversubscribed round was led by Index Ventures, alongside Kleiner Perkins, Sequoia Capital, and Dimension, with strategic backing from existing investors OpenAI and
